Randomized Trial of Activated Marrow Infiltrating Lymphocytes Alone or in Conjunction With an Allogeneic GM-CSF-based Myeloma Cellular Vaccine in the Autologous Transplant Setting in Multiple Myeloma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Multiple myeloma vaccine (Primary) ; T-lymphocyte cell therapy (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
Most Recent Events
- 09 Apr 2021 Biomarkers information updated
- 23 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 15 Jan 2013 Planned end date changed from 1 Dec 2012 to 1 Dec 2015 as reported by ClinicalTrials.gov.